Clinical Trials

12 enrolled

Gynecologic

Endometrial Serous Adenocarcinoma

NCT06011772 2026-03-11

EGF-Depleting Therapy CIMAvax-EGF in Combination With Standard Therapy for RAS- and BRAF Wild-Type Metastatic Colorectal Cancer

2 enrolled

Gastrointestinal

Colonic Neoplasms

NCT05076513 2026-03-09

Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma

42 enrolled

Glioblastoma, Glioma

NCT05182905 2026-03-09

AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma Patients

97 enrolled

Glioblastoma, Glioma

NCT02812420 2026-03-05

Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before Surgery

54 enrolled

Hydronephrosis, Ureteral Neoplasms, Urethral Neoplasms

NCT03128866 2026-03-05

Tranexamic Acid in Reducing Blood Loss in Patients With Pelvic Tumors Undergoing Hemipelvectomy Surgery

80 enrolled

Pelvic Mass

NCT03832569 2026-03-05

Study of Pembrolizumab Following Surgery in Patients With Microsatellite Instability High (MSI-H) Solid Tumors

17 enrolled

Pathologic Complete Response

NCT05035706 2026-03-05

Anti-Leukemia Immune Responses After Irradiation of Extramedullary Tumors

Other hematologic neoplasm

10 enrolled

Leukemia, Myeloid, Leukemia, Myeloid, Acute

NCT03164486 2026-02-27

First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide

BreastGastrointestinalThoracic

27 enrolled

Breast Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

NCT07435415 2026-02-27

Local Injection Methylene Blue Combined With Radiation in HNSCC Patients

10 enrolled

Head & Neck

Head and Neck Neoplasms

NCT03943173 2026-02-25

Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery

15 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT03334500 2026-02-20

Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Prostate Cancer

30 enrolled

Prostatic Neoplasms

NCT04993261 2026-02-19

An Investigational Scan (Dual Energy CT) in Detecting Gastrointestinal Carcinoid Tumors

71 enrolled

Endocrine

Carcinoid Tumor, Serotonin Syndrome

NCT03771651 2026-02-17

Short Term Aspirin on the Biologic and Immunologic Changes of the Fallopian Tube

18 enrolled

Gynecologic

Fallopian Tube Neoplasms

NCT03970226 2026-02-17

Tocilizumab in Children With ACP

9 enrolled

Craniopharyngioma

NCT05160597 2026-02-12

Image-Guided (68Ga-PSMA-11 PET/CT) Prostate Biopsy for the Diagnosis of Prostate Cancer in Men With Prior Negative/Inconclusive Biopsy

30 enrolled

Prostatic Neoplasms

NCT03387553 2026-02-09

HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer

31 enrolled

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT05333874 2026-02-09

CIPHER Study: Pilot Study to Study the Role of ctDNA in Triple Negative and HER2 Positive Early Stage

34 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05406700 2026-02-09

Niraparib In Recurrent IDH 1/2 Gliomas

16 enrolled

Glioma

NCT05358938 2026-02-06

Exercise to Boost Response to Checkpoint Blockade Immunotherapy

22 enrolled

Dermatologic

Melanoma, Motor Activity, Skin Neoplasms, Carcinoma, Merkel Cell

NCT03543969 2026-02-05

Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma

14 enrolled

Dermatologic

Melanoma, Skin Neoplasms

NCT02603887 2026-01-29

Pembrolizumab in Treating Patients With Intermediate or High-Risk Smoldering Multiple Myeloma

20 enrolled 12 charts

Plasma cell

Smoldering Multiple Myeloma

NCT05477823 2026-01-28

Imaging and Genomic Biomarkers to Predict Response in Prostate Cancer

30 enrolled

Prostatic Neoplasms

NCT04018053 2026-01-27

18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy

16 enrolled 3 charts

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT04733027 2026-01-22

Clever Peptide

57 enrolled

Other solid neoplasm

Metastatic Solid Tumor Cancer

NCT04040088 2026-01-08

An Investigational Scan (68Ga-DOTATATE PET/CT) in Diagnosing Pediatric Metastatic Neuroendocrine Tumors

20 enrolled

Ganglioneuroma, Neuroblastoma, Ganglioneuroblastoma

NCT04514029 2026-01-08

Neurotoxicity Prophylaxis With Intrathecal Dexamethasone and Simvastatin Post Axi-Cel

37 enrolled

Lymphoid

Lymphoma, Neurotoxicity Syndromes

NCT05108428 2026-01-08

Adaptive Radiation for Locally Advanced Rectal Adenocarcinoma

20 enrolled

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

NCT05245682 2026-01-08

Tolinapant and Radiation for Cisplatin-Ineligible, Previously Untreated, Locally Advanced Head and Neck Cancer

Head & NeckOther solid neoplasm

10 enrolled 8 charts

Head and Neck Carcinoma of Unknown Primary

NCT02210117 2026-01-07

Nivolumab With or Without Bevacizumab or Ipilimumab Before Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed by Surgery

104 enrolled

Carcinoma, Renal Cell

NCT04656535 2026-01-07

AB154 Combined With AB122 for Recurrent Glioblastoma

46 enrolled

Glioblastoma, Recurrence

NCT05091866 2026-01-07

Natural Progesterone for the Treatment of Recurrent Glioblastoma

4 enrolled

CNSSarcoma

Glioblastoma, Gliosarcoma

NCT05336266 2026-01-06

KetoROCX

28 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT04370483 2026-01-05

Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma

1 enrolled

Plasma cell

Smoldering Multiple Myeloma

NCT05560399 2026-01-02

CC-220

7 enrolled

Plasma cell

Multiple Myeloma

NCT05868486 2026-01-02

Analysis of Whole Body Magnetic Resonance Imaging and Liquid Biopsy for Early Detection of Cancer in Patients With a Strong Family History of Cancer